VITT (vaccine-induced immune thrombocytopenia and thrombosis) is a rare blood clotting condition linked to adenovirus-based COVID vaccines, such as the AstraZeneca jab.

Discover the molecular mechanisms behind severe blood clots linked to specific COVID-19 vaccines, revealing crucial insights for future vaccine safety.

Aplagon doses first patient in phase 2a trial of APAC with peripheral arterial occlusive disease/chronic limb threatening ischemia: Helsinki, Finland Saturday, March 14, 2026, 18: ...

While exotoxins dominate discussions of bacterial infections, endotoxins-cell wall components released upon bacterial death-are equally dangerous. These endotoxins trigger hyperinflammatory responses ...

As a common production contaminant, trace endotoxin triggers immune responses, skews results, and jeopardizes patient safety--risks that are critical in immunology, cell/gene therapy, and vaccine ...

Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...

While exotoxins dominate discussions of bacterial infections, endotoxins-cell wall components released upon bacterial death-are equally dangerous. These ...

For Andrew Hall, a veteran of Big Pharma-turned biotech builder, he has spent much of his recent career operating inside those constraints — and learning how to lead through them. Today, as CEO of ...

Is daily aspirin safe for everyone? Discover the truth behind common aspirin myths and what experts recommend.

Contrary to what the TikTok world will have you believe, it's the simpler beauty steps that will help increase your collagen ...

In the rapidly evolving landscape of regenerative medicine, 2026 has marked a turning point in how we approach recovery. We ...